| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:490652802:1795 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:490652802:1795?format=raw |
LEADER: 01795cam a2200433 a 4500
001 3939663
005 20221027004048.0
008 890112s1988 sz a b 100 0 eng
010 $a 88007478
020 $a3764322519 :$c$28.00F (est.)
020 $a0817622519 (U.S.)
035 $a(OCoLC)18521837
035 $a(OCoLC)ocm18521837
035 $a(CStRLIN)NYCM89-B154
035 $9ADK2778HS
035 $a(NNC)3939663
035 $a3939663
040 $dNjR
050 00 $aRM319$b.N66 1988
082 0 $a615/.783$219
090 $aRM319$b.N66 1988
245 00 $aNon-opioid (OTC) analgesics :$brisks/benefits in perspective /$cedited by K. Brune.
260 $aBasel ;$aBoston :$bBirkhäuser Verlag,$c1988.
300 $a76 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAgents and actions supplements ;$vAAS 25
500 $aPapers presented at a symposium sponsored by American Home Products Corp., Bayer AG, and Hoechst AG.
504 $aIncludes bibliographies.
650 0 $aAnalgesics$xEffectiveness$vCongresses.
650 0 $aAntipyretics$xEffectiveness$vCongresses.
650 0 $aHealth risk assessment$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2008105537
650 0 $aDrugs, Nonprescription$xEffectiveness$vCongresses.
700 1 $aBrune, Kay.$0http://id.loc.gov/authorities/names/n80140490
710 2 $aAmerican Home Products Corporation.$0http://id.loc.gov/authorities/names/n85014186
710 2 $aBayer AG.$0http://id.loc.gov/authorities/names/n97053225
710 2 $aHoechst AG.$0http://id.loc.gov/authorities/names/n81112953
830 0 $aAgents and actions supplements ;$vAAS 25.$0http://id.loc.gov/authorities/names/n42001287
852 00 $boff,hsl$hRM319$i.N66 1988